Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7 | 0 | 1 | N/A | 2 |
| Other current assets | 0 | -18 | 0 | 0 | 0 |
| TOTAL | $554 | $314 | $336 | $99 | $113 |
| Non-Current Assets | |||||
| PPE Net | 13 | 16 | 18 | 33 | 38 |
| Other Non-Current Assets | 420 | 420 | 0 | 0 | 90 |
| TOTAL | $432 | $435 | $18 | $33 | $128 |
| Total Assets | $986 | $767 | $355 | $133 | $240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 714 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,434 | 1,995 | 2,053 | 1,939 | 1,589 |
| Accrued Expenses | 125 | 110 | 77 | 57 | 63 |
| Other current liabilities | 574 | 495 | 549 | 233 | 294 |
| TOTAL | $4,452 | $3,799 | $3,543 | $2,768 | $2,316 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 137 | 162 | 334 | 405 |
| TOTAL | $N/A | $137 | $162 | $334 | $405 |
| Total Liabilities | $4,452 | $3,936 | $3,705 | $3,102 | $2,720 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 725 | 719 | 693 | 543 | 449 |
| Common Shares | 107 | 95 | 81 | 204 | 186 |
| Retained earnings | -9,039 | -8,089 | -6,726 | -4,190 | -5,222 |
| TOTAL | $-3,467 | $-3,169 | $-3,350 | $-2,969 | $-2,480 |
| Total Liabilities And Equity | $986 | $767 | $355 | $133 | $240 |